{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:25:32Z","timestamp":1777339532500,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejpn.2007.09.004","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T21:17:08Z","timestamp":1195075028000},"page":"321-327","source":"Crossref","is-referenced-by-count":36,"title":["Add-on levetiracetam in children and adolescents with refractory epilepsy: Results of an open-label multi-centre study"],"prefix":"10.1016","volume":"12","author":[{"given":"Petra M.C.","family":"Callenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem Frans M.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"ten Houten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Augustijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Boudewijn","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els A.J.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Stroink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada T.","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oebele F.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2007.09.004_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejpn.2007.09.004_bib2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of levetiracetam in children","volume":"42","author":"Pellock","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.09.004_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2006.12.005","article-title":"Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate","volume":"74","author":"Fountain","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejpn.2007.09.004_bib4","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejpn.2007.09.004_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.09.004_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/088307380201700603","article-title":"Levetiracetam in refractory pediatric epilepsy","volume":"17","author":"Wheless","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2007.09.004_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"Nakken","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1090-3798(03)00041-2","article-title":"Effect of levetiracetam in refractory childhood epilepsy syndromes","volume":"7","author":"Lagae","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2007.09.004_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1059-1311(03)00193-6","article-title":"Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience","volume":"13","author":"Tan","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2004.10.004","article-title":"Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial","volume":"14","author":"Lagae","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","article-title":"Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy","volume":"14","author":"Grosso","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.seizure.2005.08.002","article-title":"Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany","volume":"14","author":"Opp","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib13","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2007.09.004_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2006.12.001","article-title":"Retention rate of levetiracetam in children with intractable epilepsy at 1 year","volume":"16","author":"Peake","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.seizure.2007.02.004","article-title":"Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy","volume":"16","author":"Grosso","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2007.09.004_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.09.004_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.09.004_bib18","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1177\/0091270003258173","article-title":"Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750mg) and 750-mg tablets","volume":"43","author":"Coupez","year":"2003","journal-title":"J Clin Pharmacol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379807001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379807001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:55:53Z","timestamp":1546476953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379807001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1090379807001638"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2007.09.004","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}